Pfizer Stock News

FDA Wants Until 2076 To Fully Release Pfizer Vaccine Data: Lawsuit Authored by attorney Aaron Siri via Injecting Freedom (emphasis ours), The FDA has asked a federal judge to make the public wait until the year 2076 to disclose all of the data and information it relied upon to license Pfizers COVID-19 vaccine . That is not a typo. It wants 55 years to produce this information to the public. As explained in a prior article , the FDA repeatedly promised full transparency with regard to Covid-19 vaccines, including reaffirming the FDAs commitment to transparency when licensing Pfizers COVID-19 vaccine. With that promise in mind, in August and immediately following approval of the vaccine, more than 30 academics, professors, and scientists from this countrys most prestigious universities requested the data and information submitted to the FDA by Pfizer to license its COVID-19 vaccine . The FDAs response? It produced nothing . So, in September, my firm filed a lawsuit against the FDA on behalf of this group to demand this information.

On October 29, the Food and Drug Administration granted emergency use authorization of the Pfizer COVID-19 vaccine in children aged 5 to 11. Four days later, the Centers for Disease Control and Prevention recommended the vaccine for this age group, expanding its eligibility to 28 million kids. And while more than one million children have […]

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). To receive Global Research’s Daily Newsletter (selected articles), click here . Visit … The post Vaccine Injury Attorney Suing the FDA: FDA Asks Federal Judge to Grant it Until the Year 2076 to Fully Release Pfizer’s COVID-19 Vaccine Data appeared first on Global Research .

Pfizer Inc has signed a $5.29 billion deal with the US government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year, the drugmaker said on Thursday.The oral drug

The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators approve it

(RTTNews) - Pfizer Inc. (PFE) has made a $15 million equity investment in Cardiff Oncology Inc. (CRDF), as part of the Pfizer Breakthrough Growth Initiative, Cardiff said in a statement on Thursday. Pfizer Breakthrough Growth Initiativ is a program focused on funding innovative science to meet patient needs. In Thursday pre-market trade, CRDF

Reuters Ratio''d Into Oblivion After Fact Check Fail Defending Bill Gates After Bill Gates told a UK think tank earlier this month that the Covid-19 vaccine ''helps you with your health, but only slightly reduces transmission ," a flood of people pointed out that the billionaire vaccine proponent had essentially said the quiet part out loud - admitting that the Pfizer and Moderna mRNA vaccines ''don''t work well'' and was ''an explicit acknowledgement that the mRNA and rAdV vaccines for COVID are not working well.'' " We didnt have vaccines that block transmission. We got vaccines that help you with your health, but they only slightly reduce the transmission. So, we need a new way of doing the vaccines ," is the exact quote. Bill Gates just admitted that the Pfizer and Moderna mRNA vaccines dont work well. pic.twitter.com/6GQ3DQk8aN Ezra Levant (@ezralevant) November 9, 2021 For those who have not seen it, this is an explicit acknowledgment that the mRNA and rAdV vaccines for COVID are not working well.

The post Viatris Stock Fell in Its First Year. The CEO Sees a Unique Drug Business. appeared on BitcoinEthereumNews.com . Text size Viatris CEO Michael Goettler. Courtesy Viatris Investors have yet to warm to Viatris, created a year ago this week by the merger between a Pfizer spinoff and the generic drugmaker Mylan,

Voxzogo could reach blockbuster status with sales of $1 billion Related Stocks: BMRN , ASND , BBIO , PFE ,

The FDA and CDC could expand eligibility of the Pfizer booster shot as early as this week. The drugmaker is also seeking emergency use authorization for its COVID-19 antiviral pill, Paxlovid. CBS News'' Naomi Ruchim reports, and then Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, joins CBSN''s Tanya Rivero to discuss the latest progress in the fight against the coronavirus pandemic.

Disney''s announcement follows the US''s decision to greenlight a lower dose of the Pfizer vaccine for children who are at least five years old.

WHETHER or not you are offered the Pfizer/BioNTech or Moderna Covid vaccine is down to the supplies available on the day at the local pharmacy or vaccine centre that you attend. Read more here Daily Express :: Health Feed Covid booster vaccine: More side effects likely for third jab here is why

Bloomberg Markets and Finance published this video item, Read more